SABESP(SBS) - 2024 Q4 - Earnings Call Presentation
2025-03-25 16:41
EARNINGS CALL 2024 SAFE HARBOR STATEMENT This presentation does not contain projections or estimates of future events. However, it may include forward-looking statements that indicate potential trends related to Sabesp, based on the reasonable expectations, beliefs, and assumptions of the Company's management. The use of expressions such as "projects," "estimates," "anticipates," "foresees," "plans," "expects," and similar terms shall not be construed as forecasts or guidance for purposes of applicable regu ...
Enerpac Tool(EPAC) - 2025 Q2 - Earnings Call Presentation
2025-03-25 14:43
2 Q2 Fiscal 2025 Revenue | ($ in millions) | | | | | | | --- | --- | --- | --- | --- | --- | | | Net Sales | Net Sales | | | Organic | | | 2Q25 | 2Q24 | | Change | Growth* | | Industrial Tools & Service (IT&S) | $141 | $135 | 4 . | 4% | 4 2% . | | IT&S Product | $114 | $108 | 5 . | 5% | 4 4% . | | IT&S Service | $27 | $27 | -0 . | 2% | 3 4% . | | Other (Cortland Biomedical) | $5 | $4 | 33 . | 1% | 33 1% . | | Enerpac Tool Group | $146 | $138 | 5 . | 1% | 5 0% . | Q2 FY25 EARNINGS 3.25.2025 Forward-Looking S ...
PAVmed(PAVM) - 2024 Q4 - Earnings Call Presentation
2025-03-25 14:21
Nasdaq: PAVM, PAVMZ Q4 2024 Business Update March 25, 2025 LISHAN AKLOG, MD Chairman & CEO DENNIS MCGRATH President & CFO Nasdaq: PAVM Nasdaq: LUCD Early Detection of Esophageal Precancer D I A G N O S T I C S Privately Held Digital Cancer Care Platform & Smart Vascular Access Port D I G I T A L H E A L T H Privately Held Incubator for MedTech Technologies, including PortIO, EsoCure, and CarpX M E D T E C H PMX Privately Held TBD T B D TBD Privately Held TBD T B D TBD Disclaimer ▪ This presentation may cont ...
Solar(CSIQ) - 2024 Q4 - Earnings Call Presentation
2025-03-25 11:37
Canadian Solar 4Q24 Earnings Call March 25, 2025 Canadian Solar Inc. Safe Harbor Statement This presentation has been prepared by the Company solely to facilitate the understanding of the Company's business model and growth strategy. The information contained in this presentation has not been independently verified. No representation, warranty or undertaking, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the ...
KB Home(KBH) - 2025 Q1 - Earnings Call Presentation
2025-03-24 23:32
Investor Presentation First Quarter 2025 1 Forward-Looking Statements Items in this presentation, and statements by KB Home management in relation to this presentation or otherwise, may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current (at the time made) expectations and projections about future events and are subject to risks, uncertainties, and assumptions about our operations, economic and market fac ...
Oncocyte(OCX) - 2024 Q4 - Earnings Call Presentation
2025-03-24 21:20
Investor Presentation NASDAQ: OCX March 2025 oncocyte.com Forward looking statements Safe-Harbor Statement This presentation and the accompanying oral presentation contain "forward-looking" statements that are based on Oncocyte's management's beliefs and assumptions and on information currently available to management. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates," "may," and ...
Lucid Diagnostics(LUCD) - 2024 Q4 - Earnings Call Presentation
2025-03-24 13:51
Nasdaq: LUCD Q4 2024 Business Update Lishan Aklog, M.D. Chairman & CEO Highlights ▪ Commercial Execution Record quarterly test volume 4 – 4Q24 Revenue $1.2M – 4Q24 EsoGuard test volume 4,042: +45% Quarterly March 24, 2025 Lishan Aklog MD Dennis McGrath Chairman & CEO CFO Disclaimer 2 ▪ This presentation may contain certain forward-looking statements related to or Lucid Diagnostics Inc. (the "Company") that involve risks and uncertainties. ▪ Actual results and events may differ significantly from results and ...
Intuitive Machines(LUNR) - 2024 Q4 - Earnings Call Presentation
2025-03-24 13:04
Pete McGrath CHIEF FINANCIAL OFFICER Steve Altemus CO -FOUNDER, PRESIDENT & CHIEF EXECUTIVE OFFICER DISCLAIMER AND FORWARD LOOKING STATEMENTS This presentation (and oral statements made regarding the subjects of this presentation) includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements that do not relate to matters of historical fact should be considered forward looking. These forward-looking statements generally are iden ...
Carnival (CCL) - 2025 Q1 - Earnings Call Presentation
2025-03-21 15:58
The page numbering is dependent on the placeholder text boxes on the page layout in the master view, so please DO NOT remove them Reports Record-Setting First Quarter Operating Results Outperforms December Guidance Raises Full Year 2025 Guidance First Quarter 2025 Earnings Presentation Because forward-looking statements involve risks and uncertainties, there are many factors that could cause our actual results, performance or achievements to differ materially from those expressed or implied by our forward-l ...
TELA Bio(TELA) - 2024 Q4 - Earnings Call Presentation
2025-03-21 02:06
INVESTOR PRESENTATION March 2025 Forward Looking Statements This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this document, including but not limited to statements regarding possible or assumed future results of operations, business strategies, development plans, regulatory activities, market opportunity competitive position, potential growth opportunities, a ...